Some older generic drugs have become very expensive, owing to factors including drug shortages, supply disruptions, and consolidations in the generic-drug industry. But generics manufacturers that legally obtain a market monopoly can also unilaterally raise prices.
No takes yet. Share an insight, caveat, or question.
Alpern et al. (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: